Evolving Paradigm of Prothrombin Time Diagnostics with Its Growing Clinical Relevance towards Cardio-Compromised and COVID-19 Affected Population
Prothrombin time (PT) is a significant coagulation (hemostasis) biomarker used to diagnose several thromboembolic and hemorrhagic complications based on its direct correlation with the physiological blood clotting time. Among the entire set of PT dependents, candidates with cardiovascular ailments a...
Main Authors: | Anubhuti Saha, Ashutosh Bajpai, Vinay Krishna, Shantanu Bhattacharya |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Sensors |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8220/21/8/2636 |
Similar Items
-
The effect of vitamin K on prothrombin time in critically ill patients: an observational registry study
by: Sofia Dahlberg, et al.
Published: (2021-01-01) -
Coagulation in chronic liver disease and the use of prothrombin complex concentrate for an emergent procedure: a case report and review of literature
by: Matthew Laubham, et al.
Published: (2018-05-01) -
A nonneutralizing antibody as cause of prothrombin deficiency in a patient with follicular lymphoma
by: Cecilia Augustsson, et al.
Published: (2024-01-01) -
A sensitivity comparison of the Quick and Owren prothrombin time methods in oral anticoagulant therapy
by: Juha Eero Horsti
Published: (2009-09-01) -
Prevalence of Coagulopathy in Patients with Celiac Disease: A Single-Center Retrospective Case-Control Study
by: Daniel Vasile Balaban, et al.
Published: (2023-10-01)